Clinical trial
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
NCT00226096 · The George Institute, Other · Completed
Key facts
| NCT number | NCT00226096 |
|---|---|
| Title | Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage |
| Official title | A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage |
| Lead sponsor | The George Institute, Other |
| Collaborators | National Health and Medical Research Council, Australia |
| Status | Completed |
| Study type | Interventional |
| Conditions | CVA (Cerebrovascular Accident), Cerebral Hemorrhage, Intracranial Hemorrhages |
| Intervention type | Drug |
| Interventions | Labetalol Hydrochloride, Metoprolol tartrate, Hydralazine Hydrochloride, Glycerol Trinitrate, Phentolamine mesylate, Nicardipine, Urapidil, Esmolol, Clonidine, Enalaprilat and 1 more |
| Enrollment | 404 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 26, 2005 |
| Last update posted | Jun 26, 2008 |
| Countries | Australia, China, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: